Tarun Bhargava, MD
Adult Reconstructive Orthopaedic Surgery · Wichita, KSNPI 1952527442
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.5%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. Encore Medical, LP accounts for 88.8% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $130,652 and has fallen 65.8% since, to $44,680 in 2025.
Across 408 payments — averaging $1308.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$474K
- Orthalign Inc$45K
- Innovation Technologies Inc$11K
- Pacira Pharmaceuticals Incorporated$1K
- Stryker$1K
- Conformis, Inc.$223
- plus $752 from 11 others
Across 3 payments — averaging $961.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Encore Medical, LP$3K
Across 7 payments — averaging $37,189 each. An ownership or investment interest held by the physician or an immediate family member.
- Midwest Surgical Alliance, LLC$260K
What the payments were for
- Royalty or licence$179,36634%
- Consulting fees$306,98558%
- Speaking & faculty fees$5,6681%
- Travel & lodging$34,3206%
- Food & beverage$7,4591%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 331 | $473,887 |
| Orthalign Inc | 23 | $45,193 |
| Innovation Technologies Inc | 9 | $11,452 |
| Pacira Pharmaceuticals Incorporated | 6 | $1,154 |
| Stryker | 9 | $1,137 |
| Conformis, Inc. | 3 | $223 |
| Anika Therapeutics, Inc. | 3 | $200 |
| Medacta USA, Inc. | 3 | $168 |
| Pacira Therapeutics, Inc. | 5 | $73 |
| Avanos Medical | 2 | $73 |
| Ferring Pharmaceuticals Inc. | 4 | $58 |
| Johnson & Johnson(2 entities) | 3 | $57 |
| Bioventus LLC | 2 | $31 |
| Fidia Pharma USA Inc. | 2 | $28 |
| Restor3d, Inc. | 1 | $28 |
| Vertex | 1 | $18 |
| Organogenesis Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO SURGICAL$356,853
- DJO Surgical Empowr Knee System$109,066
- DJO Surgical TaperFill Hip System$50,130
- OrthAlign Plus System$44,838
- Irrisept$11,435
- DJO Surgical 3DKnee System$6,234
- DJO Surgical Foundation Hip System$6,075
- DJO Surgical AltiVate Reverse$4,650
- DJO Surgical AltiVate Anatomic System$3,375
- DJO Surgical Discovery Elbow System$3,375
- DJO Surgical Exprt Revision Hip$1,535
- DJO Surgical Linear Hip System$1,350
- DJO Surgical FMP Acetabular System$1,350
- Iovera$1,049
- MAKO$987
- DJO Surgical CLP Hip System$916
- DJO Surgical Cobalt HV Bone Cement$834
- ORTHALIGN PLUS$155
- Hip$147
- Identity Imprint CR$147
How this compares
Too few adult reconstructive orthopaedic surgery providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 484 | $656 |
| Celecoxib | 24 | $337 |
| Clindamycin Hcl | 99 | $242 |
| Ondansetron OdtOndansetron | 16 | $81 |
| Cyclobenzaprine Hcl | 16 | $49 |
| Cephalexin | 13 | $38 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Wichita
- Paul PappademosWichita$4K
- Benjamin YoungWichita$4K
- James JosephWichita$144
- Kelly HendricksOverland Park$250K
- Jonathon SalavaTopeka$52K
- Andrew PalmisanoOverland Park$40K
- Matthew de RuyterKansas City$23K
- Michael PerryOverland Park$14K
- Andrew MurthaKansas City$9K
- Scott WingerterLeawood$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.